FDA Approves Yeztugo for HIV PrEP Lasting 6 Months

The FDA approved lenacapavir, an injectable HIV-1 capsid inhibitor, to be used as PrEP to reduce the risk of sexually acquired HIV in adults and adolescents, making it the first twice-yearly option for Americans who need or want PrEP.